Related Experiment Video
Updated: Jul 14, 2026

An Unpredictable Chronic Mild Stress Protocol for Instigating Depressive Symptoms, Behavioral Changes and Negative Health Outcomes in Rodents
Published on: December 2, 2015
Major depressive disorder and inflammatory markers in elderly patients with heart failure
Anna Maria Andrei1, Renerio Fraguas, Renata M S Telles
1Heart Institute, University of São Paulo School of Medicine, São Paulo, SP, Brazil.
Insights
Older adults with chronic heart failure (CHF) and major depressive disorder (MDD) show elevated high-sensitivity C-reactive protein. This inflammatory marker was significantly higher in CHF patients with MDD compared to healthy controls.
Area of Science:
- Geriatric Medicine
- Cardiology
- Psychiatry
- Immunology
Background:
- Chronic heart failure (CHF) is a prevalent condition in older adults, often co-occurring with other health issues.
- Major depressive disorder (MDD) is frequently observed in patients with CHF, potentially exacerbating symptoms and impacting prognosis.
- Inflammation plays a crucial role in the pathophysiology of both CHF and MDD.
Purpose of the Study:
- To investigate and compare inflammatory marker levels in elderly patients with CHF, with and without comorbid MDD.
- To assess differences in specific inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP), tumor necrosis factor-alpha (TNF-α), and interleukin-6 (IL-6), across the study groups.
Main Methods:
- Study included 34 elderly outpatients (≥65 years) with CHF (left-ventricular ejection fraction <0.40, NYHA class II/III) and 13 healthy controls.
- CHF patients were categorized based on the presence (N=18) or absence (N=16) of major depressive disorder (MDD), diagnosed using the SCID DSM-IV.
- Serum levels of hs-CRP, TNF-α, and IL-6 were measured and compared among the three groups.
Main Results:
- Patients with CHF and MDD exhibited significantly higher levels of high-sensitivity C-reactive protein (hs-CRP) compared to healthy-control subjects.
- No significant differences in tumor necrosis factor-alpha (TNF-α) or interleukin-6 (IL-6) levels were observed among the chronic heart failure (CHF) patients (with or without MDD) and the healthy-control group.
Conclusions:
- Elevated hs-CRP may serve as a potential biomarker for the co-occurrence of major depressive disorder (MDD) in elderly patients with chronic heart failure (CHF).
- Further research is warranted to explore the specific inflammatory pathways involved and their clinical implications in this patient population.
Abstract:
The authors evaluated levels of inflammatory markers in 34 chronic heart failure (CHF) out-patients age 65 years and over, with (N=18) and without (N=16) major depressive disorder (MDD), and healthy-control subjects (N=13). Patients with CHF had left-ventricular ejection fractions <0.40 and were in the New York Heart Association functional class II or III. The authors used the SCID DSM-IV to diagnosis MDD. High-sensitivity C-reactive protein levels were significantly higher in patients with CHF and MDD as compared with healthy-control subjects. No differences regarding tumor necrosis factor(alpha) or interleukin(6) were found among the three groups.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Heart Failure III: Clinical Manifestations
Depressive Disorders: MDD and Dysthymia
Stress and Mental Health
Individuals with depression often experience challenges in both their personal and professional...
Heart Failure II: Pathophysiology
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies